Bioanalysis data analysis

Typically, a PK study is composed of three phases, namely the in-life phase, bioanalysis, and data analysis. The in-life phase includes administering the compound to animals or humans and collecting samples from an appropriate matrix of interest such as blood or urine at predetermined time intervals for bioanalysis. The bioanalytical phase involves analysis of a drug and/or its metabohte(s) concentration in blood, plasma, serum, or urine. This analysis typically involves sample extraction and detection of analytes via LC-MS/MS. The third phase is data analysis using noncompartmental or compartmental PK computational methods. 

The general process of bioanalysis is depicted in Figure 6.3. Following animal dosing and biological sample collection, the typical steps in the bioanalytical procedure are sample preparation, chromatographic separation, MS detection, and data analysis, aU of which are critical in determining assay quality [101-103]. 

The high-throughput concept for quantitative bioanalysis applies to steps such as assay development, sample collection and sorting, sample preparation, sample analysis, and data processing and reporting. Those processes are closely interlinked and improvement of process throughput is equally important. 

In addition to these qualitative studies, quantitative bioanalysis, e.g., in preclinical and clinical studies to provide pharmacokinetic and pharmacodynamic data, is an essential part of drug development. Quantitative bioanalysis is the most important application area of LC-MS, in terms of number of instruments applied and the number of analyses performed. Fast, high-throughput, and routine quantitative analysis by LC-MS also demands fast and automated sample pretreatment strategies and advanced data-processing software. 

---